ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

A 4-Week Study of the Safety, Efficacy, and Pharmacokinetics of JZP-110 [(R)-2-amino-3-phenylpropylcarbamate Hydrochloride] in Subjects With Parkinson's Disease and Excessive Sleepiness

ClinicalTrials.gov ID: NCT03037203

Public ClinicalTrials.gov record NCT03037203. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 5, 2026, 7:17 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A 4-Week, Double-blind, Placebo-controlled, Randomized, Multicenter, Crossover Study of the Safety, Efficacy, and Pharmacokinetics of JZP-110 [(R)-2-amino-3-phenylpropylcarbamate Hydrochloride] in Subjects With Parkinson's Disease and Excessive Sleepiness

Study identification

NCT ID
NCT03037203
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Jazz Pharmaceuticals
Industry
Enrollment
66 participants

Conditions and interventions

Interventions

  • JZP-110 Drug
  • Placebo Other

Drug · Other

Eligibility (public fields only)

Age range
35 Years to 80 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 31, 2016
Primary completion
Jul 31, 2018
Completion
Jul 31, 2018
Last update posted
Jan 8, 2020

2017 – 2018

United States locations

U.S. sites
25
U.S. states
14
U.S. cities
25
Facility City State ZIP Site status
Southern California Institute For Respiratory Diseases, Inc. Los Angeles California 90048
Pacific Research Network, Inc San Diego California 92103
Alpine Clinical Research Center Boulder Colorado 80301
Rocky Mountain Movement Disorders Center, PC Englewood Colorado 80113
Parkinson's Disease and Movement Disorders Center of Boca Raton Boca Raton Florida 33486
PAB Clinical Research Brandon Florida 33511
MD Clinical Hallandale Florida 33009
QPS MRA (Miami Research Associates) Miami Florida 33143
Bioclinica Research Orlando Florida 32806
USF Health Byrd Institute Tampa Florida 33613
Rush University Medical Center Chicago Illinois 60612
University of Kansas Medical Center Research Institute, Inc. Kansas City Kansas 66160
Center for Sleep & Wake Disorders Chevy Chase Maryland 20815
QUEST Research Institute Farmington Hills Michigan 48334
Clinical Neurophysiology Services, P.C. Sterling Heights Michigan 48314
Henry Ford Medical Center - West Bloomfield West Bloomfield Michigan 48322
St. Lukes Hospital Medical Center Chesterfield Missouri 63017
Strong Sleep Disorders Center Rochester New York 14618
Montefiore Sleep-Wake Disorders Center The Bronx New York 10467
Lynn Health Science Institute Oklahoma City Oklahoma 73112
Parkinson's Disease Research Unit - Thomas Jefferson University Philadelphia Pennsylvania 19107
SleepMed of South Carolina Columbia South Carolina 29201
Villages at Vanderbilt Nashville Tennessee 37232
Evergreen Hospital Medical Center Kirkland Washington 98034
Premier Clinical Research - Sherman Spokane Washington 99202

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03037203, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 8, 2020 · Synced May 5, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03037203 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →